167 related articles for article (PubMed ID: 11819863)
1. p16 gene methylation in colorectal cancers associated with Duke's staging.
Yi J; Wang ZW; Cang H; Chen YY; Zhao R; Yu BM; Tang XM
World J Gastroenterol; 2001 Oct; 7(5):722-5. PubMed ID: 11819863
[TBL] [Abstract][Full Text] [Related]
2. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
[TBL] [Abstract][Full Text] [Related]
4. P16 methylation in serum as a potential marker for the malignancy of colorectal carcinoma.
Nakayama G; Hibi K; Kodera Y; Koike M; Fujiwara M; Nakao A
Anticancer Res; 2007; 27(5A):3367-70. PubMed ID: 17970082
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Wu MS; Wang SM; Lin JT; Cheng AL
Oncology; 1999; 57(2):149-56. PubMed ID: 10461063
[TBL] [Abstract][Full Text] [Related]
6. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
7. p16 gene methylation in colorectal cancer patients with long-term follow-up.
Veganzones-de-Castro S; Rafael-Fernández S; Vidaurreta-Lázaro M; de-la-Orden V; Mediero-Valeros B; Fernández C; Maestro-de las Casas ML
Rev Esp Enferm Dig; 2012 Mar; 104(3):111-7. PubMed ID: 22449151
[TBL] [Abstract][Full Text] [Related]
8. p16 Gene methylation in colorectal tumors: correlation with clinicopathological features and prognostic value.
Sanz-Casla MT; Maestro ML; Vidaurreta M; Maestro C; Arroyo M; Cerdán J
Dig Dis; 2005; 23(2):151-5. PubMed ID: 16352895
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
11. CpG island methylation in familial colorectal cancer patients not fulfilling the Amsterdam criteria.
Kim HC; Lee HJ; Roh SA; Kim JS; Yu CS; Kim JC
J Korean Med Sci; 2008 Apr; 23(2):270-7. PubMed ID: 18437011
[TBL] [Abstract][Full Text] [Related]
12. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
[TBL] [Abstract][Full Text] [Related]
13. [Methylation status of p16 gene in colorectal carcinoma and normal colonic mucosa].
Zhang J; Lai M; Chen J
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):95-8. PubMed ID: 11866898
[TBL] [Abstract][Full Text] [Related]
14. CpG island methylation in colorectal adenomas.
Rashid A; Shen L; Morris JS; Issa JP; Hamilton SR
Am J Pathol; 2001 Sep; 159(3):1129-35. PubMed ID: 11549606
[TBL] [Abstract][Full Text] [Related]
15. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer.
Wiencke JK; Zheng S; Lafuente A; Lafuente MJ; Grudzen C; Wrensch MR; Miike R; Ballesta A; Trias M
Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):501-6. PubMed ID: 10385139
[TBL] [Abstract][Full Text] [Related]
18. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H
Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139
[TBL] [Abstract][Full Text] [Related]
19. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
